Allegro MicroSystems, Inc. ( NASDAQ: ALGM) Q4 2025 Earnings Call May 8, 2025 8:30 AM ET Jalene Hoover - Investor Relations Mike Duke - President and Chief Executive Officer Derek D’Antilio - Chief ...

Provides ReciBioPharm's customers with access to NewBiologix's Xcell-Eng-HEK293 cell lines for advanced therapies <l ...

Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites open to date Initiation of second 4D-150 Phase 3 clinical trial (4FRONT-2) ...

Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ETCompany ParticipantsCarrie Gillard - Director, IRHarley Finkelstein ...

Company currently initiating additional trial sites and working with study investigators to enroll participants IMNN-001 is the first and only immunotherapy to show meaningful overall survival benefit ...

An hour after white smoke billowed from the Vatican, newly minted Pope emerged on the historic balcony to the world & 1.4 ...

Lightspeed Commerce Inc. ("Lightspeed" or the "Company"), the one-stop commerce platform empowering merchants to provide the ...

Cities from London to Moscow are holding events this week as the world observes Thursday’s 80th anniversary of Victory in ...

The Global Virus Network (GVN), in partnership with The University of the West Indies (UWI) Mona Campus and the State ...

HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram disease-driving cell states for rare, common, chronic and ...